• Competitive mortality in patients witch Neuroendocrine tumors
  • Mohammad Salari,1 Hamid Hosseini,2 Fateme Bahoosh Feyzabadi,3 Fateme Teymoorzade,4,*
    1. Biology Department, Faculty of Basic Science, Islamic Azad University, Mashhad, Iran
    2. MaLaboratory Dciences Department, Faculty of Paramedical Sciences, Islamic Azad University, Mashhad, Iran
    3. Medicine Department, Faculty Medical Science, Islamic Azad University, Shahrood, Iran
    4. Nuclear medicine,Faculty of Paramedical Sciences, university of medical science,babol,iran


  • Introduction: Our objectives are to evaluate the hospital prevalence of neuroendocrine tumors, the primary origin of the tumor, the degree of compliance between pathologic and immunohistochemical diagnoses, and the ability of these markers to determine the prognosis and survival rate of patients (in addition to the primary characteristics and clinical course).
  • Methods: Searching for keywords with the title / abstract filter in the pubmed database found 48 articles out of which 20 were studied, of which 10 were used for this review study.
  • Results: Merkel Cell Cancer (MCC) is a rare but fatal cancer. Pancreatic head tumors are one of the leading causes of cancer deaths in Western countries. Laparoscopic pancreaticoduodenectomy is a feasible procedure. Melanoma is the most aggressive type of skin cancer that is limited by imaging and light-based imaging techniques near the tumor surface. Heavy ions and HF10 are important directions for the treatment of melanoma in the future. Future advances aim to extend the lifespan of melanoma patients rather than treat them.Timely detection of adrenal tumors in pregnancy is important because failure to do so can lead to death.
  • Conclusion: Studies have concluded that deaths can be prevented if patients are identified and informed in a timely manner.
  • Keywords: Competitive, Neuroendocrine, Tumors